Call Us: +44 (0) 1752 753723[email protected]

Bone marrow cells show promise in degenerative, ischemic retinal diseases

Pilot study suggests a role for autologous intravitreal CD34+ cells. The safety and feasibility of intravitreal autologous CD34+ bone marrow cells as a potential therapy for retinal disease were evaluated in a pilot study. Preliminary findings demonstrated the treatment was feasible and researchers intend to pursue a larger, prospective...

Matching donor found for Langley father-of-two with blood cancer

The family of a man from Langley who desperately needed a matching blood cell donor have spoken out about their joy of a donor being found. Raj Bhuller, from Langley, was diagnosed with acute myeloid leukaemia, a form of blood cancer, on Christmas Eve and has remained at Wexham...

Stem cell treatment offers new hope for Aimee

For Aimee Seddon even a loving hug from a family member can cause unbearable pain. The brave six-year-old has recessive dystrophic epidermolysis bullosa, a severe form of a disease known as EB, which leaves her with painful blisters and scarring. Her parents wrap her from neck to toe in...

stem-cells

Stem Cell therapy with drugs rekindles new hope to Diabetes 2 treatment

Canada-based University of British Columbia scientists have shown for the first time that Type 2 diabetes can be tackled with a combination of specially-cultured stems cells and conventional diabetes drugs. The scientists have used stem cells to reverse the type 1 diabetes in mice and hope to apply similar...

An interview with the founder of the Prenatal Classroom

We’ve been working closely with Dr Anastasia Alcock who founded the Prenatal Classroom to provide comprehensive, evidence-based information and support for pregnant women. Here are her views on the challenges facing first-time mums, growing a business and why awareness of cord blood should be higher. 1. Anastasia, what sparked...

Why volume reduced cord blood is “the industry standard”

As the most highly accredited private cord blood bank in the UK, we’ve long argued why we volume reduce cord blood rather than storing whole blood which is also on offer if you choose to bank umbilical cord blood.  We know that this choice can be confusing for parents – especially...

Investment in knowledge continues

Having a team of the most knowledgable experts in cord blood stem cell research and development is what clearly separates us from our competition – it is the major reason why we are the most highly accredited private cord blood and tissue bank in the UK. As such, we...

Biovault Technical secures new collaboration with Swiss Company

A high-tech Plymouth based organisation has cemented its ties with a Swiss Company by signing a long term contract. Plymouth International Medical & Technology Park based Biovault Technical has been officially selected as a partner to provide cord blood banking facilities to Zurich based BioCord. Cord blood banking, a...

Grace’s story

As a participant in Duke University’s cord blood clinical trial, Grace – who has cerebral palsy – received an autogloss transplant of cord blood derived stem cells.  Her family were delighted to see a reduction in her symptoms, with significant repair to brain tissue resulting in increased mobility and a...

Umbilical cord blood used to treat Sickle Cell Disease in the UK

A boy who received an umbilical cord blood stem cell transplant to treat his Sickle Cell disease is now cured. Kosi Okoli received in late 2010, cord blood stem cells in the hope of curing his disease for which he was receiving several blood transfusions a month for. For...